This session focuses on the evolving role of alpha-glucosidase inhibitors (AGIs) in managing diabetes in Indian patients, where postprandial hyperglycemia and dietary patterns present unique challenges. It highlights patient-centric approaches, clinical evidence, and practical strategies for integrating AGIs into routine care. A relevant discussion on tailoring diabetes management to achieve effective and culturally appropriate outcomes.